[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351345-105":59,"doc-detail-351345-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","regulatory-network-and-spatial-modeling-reveal-cooperative-mechanisms-of-resistance-and-immune-escape-in-er-breast-cancer","Regulatory network and spatial modeling reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer","","Estrogen receptor-positive (ER+) breast cancer continues to challenge treatment because drug resistance can be reversible and accompanied by immune evasion. The study links reversible resistance emerging during epithelial-to-mesenchymal transition (EMT) and PD-L1–mediated immune escape. By building an ER-EMT-PD-L1 gene regulatory network and simulating coupled ordinary differential equations, it finds antagonistic epithelial/mesenchymal modules with mono-, bi-, and tristable behavior. Spatial agent-based simulations show tumor expansion requires co-existing resistance, motility, and immune evasion, and identify combination therapies that limit diversification and improve immune infiltration in silico.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/regulatory-network-and-spatial-modeling-reveal-cooperative-mechanisms-of-resistance-and-immune-escape-in-er-breast-cancer/351345/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/regulatory-network-and-spatial-modeling-reveal-cooperative-mechanisms-of-resistance-and-immune-escape-in-er-breast-cancer/351345.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the study connect EMT, drug resistance, and immune escape in ER+ breast cancer?","Question",{"text":112,"@type":113},"It constructs an ER-EMT-PD-L1 gene regulatory network and simulates how EMT-associated resistance states couple to PD-L1 expression, which drives immune evasion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What dynamical behaviors does the gene regulatory network generate?",{"text":117,"@type":113},"The overarching network produces antagonistic epithelial and mesenchymal modules capable of generating monostable, bistable, and tristable dynamics.",{"name":119,"@type":110,"acceptedAnswer":120},"When does the spatial model predict sustained tumor expansion under therapy?",{"text":121,"@type":113},"Sustained expansion occurs only when resistance, motility, and immune evasion traits coexist, and this requirement persists across different GRN landscapes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351345,1790095102,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Fan etal. BMC Cancer (2026) 26:420 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15691-2](https://doi.org/10.1186/s12885-026-15691-2)  \nRESEARCH Open Access  \nRegulatory network and spatial modeling  reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer  \nYijia Fan1,2, Sarthak Sahoo3, Mohit Kumar Jolly3* and Jason T. George 1,2,4*  \nAbstract  \nDespite significant progress, the treatment of estrogen receptor-positive (ER+) breast cancer remains clinically challenging due to reversible drug resistance and immune evasion. Drug resistance often arises as cells undergo a dynamic epithelial-to-mesenchymal transition (EMT), while elevated PD-L1 levels contribute to immune escape. While these phenotypic features can variably co-occur, the impact of co-occurrence on the availability of synergistic treatment strategies remains unknown. To investigate their interplay, we constructed an ER-EMT-PD-L1 gene regulatory network and simulated these networks as coupled ordinary differential equations with biologically informed parameters, to generate steady-state expression profiles. Our study revealed that the relevant overarching network generated antagonistic epithelial and mesenchymal modules, capable of producing monostable, bistable, and tristable dynamics. We further examined the link between phenotypes and immune evasion by quantifying average PD-L1 expression, and found that epithelial-sensitive states consistently exhibited low PD-L1 . In contrast, hybrid-and mesenchymal-resistant states were associated with a non-linear, stepwise increase in PD-L1, highlighting a strong coupling between EMT, resistance, and immune evasion. Extending on these network-level insights, we further used a spatially explicit agent-based model seeded with GRN-derived phenotypes to probe tumor behavior under therapeutic pressure. Simulations revealed that sustained tumor expansion occurred only when resistance, motility, and immune evasion traits co-existed, and this requirement remained robust across GRN landscapes with differing stability. Plasticity and multistability increased the accessible phenotypic state-space and accelerated shifts toward high-fitness resistant states. We further identified combination therapies that significantly reduced phenotypic diversification and improved immune infiltration in silico. Taken together, our modeling work links regulatory dynamics with tumor-level adaptation and highlights strategies to reprogram resistant cell states toward sensitivity, which are difficult to infer from bulk or cross-sectional data alone. In addition, it provides a controllable in silico testbed to systematically evaluate candidate treatment combinations and their effects on tumor phenotypic transitions and spatial T cell access, thereby helping to prioritize experimental regimens for follow-up.  \n*Correspondence:  \nMohit Kumar Jolly [mkjolly@iisc.ac.in](mkjolly@iisc.ac.in)[ ](mkjolly@iisc.ac.in)Jason T. George [jason.george@tamu.edu](jason.george@tamu.edu)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to ","cbCaipPpzQGdPh7D","https://ap.wps.com/l/cbCaipPpzQGdPh7D","pdf",5296987,17,"English","# Introduction\n## Mechanisms of resistance and immune evasion\n# Methods\n## ER-EMT-PD-L1 gene regulatory network\n## Coupled ordinary differential equation simulations\n## Spatial agent-based modeling\n# Results\n## Multistability and phenotype coupling\n## PD-L1 patterns across epithelial and resistant states\n## Tumor behavior under therapeutic pressure\n## Combination therapy effects","[{\"question\":\"How does the study connect EMT, drug resistance, and immune escape in ER+ breast cancer?\",\"answer\":\"It constructs an ER-EMT-PD-L1 gene regulatory network and simulates how EMT-associated resistance states couple to PD-L1 expression, which drives immune evasion.\"},{\"question\":\"What dynamical behaviors does the gene regulatory network generate?\",\"answer\":\"The overarching network produces antagonistic epithelial and mesenchymal modules capable of generating monostable, bistable, and tristable dynamics.\"},{\"question\":\"When does the spatial model predict sustained tumor expansion under therapy?\",\"answer\":\"Sustained expansion occurs only when resistance, motility, and immune evasion traits coexist, and this requirement persists across different GRN landscapes.\"}]","Regulatory network and spatial modeling reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer | PDF",1790093634,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bb152db6a178e5b6db271e4ce285b04.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b5c52c345dd3913f24ff21a265556e3.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09b464b7b98c8e953249ad72355c4c42.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b264dc5a79a0a1ffc8e8285c8f04550.webp",980,1306]